Skip to main content
. 2019 Mar 11;68(12):2161–2169. doi: 10.1136/gutjnl-2018-317366

Table 3.

The per cent of patients being ignored in each site between WISENSE and control group

Ignored sites Number (%) % Risk difference (95% CI) P value
WISENSE (n=153) Control (n=150)
Oesophagus 0 (0.00) 0 (0.00) NA NA
Squamocolumnar junction 0 (0.00) 2 (1.33) −1.33% (−4.74 to 1.14) 0.24
Antrum (G) 0 (0.00) 5 (3.33) −3.33% (−7.57 to −0.84) 0.03
Antrum (P) 4 (2.61) 15 (10.00) −7.39% (−13.56 to −2.10) 0.008
Antrum (A) 4 (2.61) 10 (6.67) −4.05% (−9.56 to 0.77) 0.10
Antrum (L) 6 (3.92) 14 (9.33) −5.41% (−11.63 to 0.20) 0.06
Duodenal bulb 1 (0.65) 6 (4.00) −3.35% (−7.89 to 0.05) 0.06
Duodenal descending 0 (0.00) 9 (6.00) −6.00% (−11.01 to −3.19) 0.002
Lower body (G) 4 (2.61) 26 (17.33) −14.72% (−21.89 to −8.48) <0.001
Lower body (P) 20 (13.07) 44 (29.33) −16.26% (−25.36 to −7.17) <0.001
Lower body (A) 11 (7.19) 28 (18.67) −11.48% (−18.29 to −4.06) 0.003
Lower body (L) 8 (5.23) 45 (30.00) −24.77% (−33.13 to −16.76) <0.001
Middle-upper body (F, G) 4 (2.61) 8 (5.33) −2.72% (−7.90 to 1.91) 0.244
Middle-upper body (F, P) 20 (13.07) 52 (34.67) −21.59% (−30.87 to −12.20) <0.001
Middle-upper body (F, A) 20 (13.07) 64 (42.67) −29.59% (−38.97 to −19.97) <0.001
Middle-upper body (F, L) 13 (8.50) 84 (56.00) −47.50% (−56.20 to −38.06) <0.001
Fundus (G) 4 (2.61) 13 (8.67) −6.05% (−11.98 to −0.95) 0.02
Fundus (P) 13 (8.50) 32 (21.33) −12.84% (−21.01 to −4.95) 0.002
Fundus (A) 22 (14.38) 26 (17.33) −2.95% (−11.35 to 5.36) 0.49
Fundus (L) 29 (18.95) 61 (40.67) −21.71% (−31.57 to −11.54) <0.001
Middle-upper body (R, P) 10 (6.54) 26 (17.33) −10.80% (−18.41 to −3.63) 0.003
Middle-upper body (R, A) 30 (19.61) 61 (40.67) −21.06% (−30.97 to −10.84) <0.001
Middle-upper body (R, L) 21 (13.73) 36 (24.00) −10.27% (−19.14 to −1.48) 0.03
Angulus (P) 42 (27.45) 96 (64.00) −36.55% (−46.50 to −25.70) <0.001
Angulus (A) 19 (12.42) 80 (53.33) −40.92% (−50.09 to −31.04) <0.001
Angulus (L) 5 (3.27) 29 (19.33) −16.07 (−23.51 to −9.42) <0.001